EMGuidance provides mobile access to local clinical information

EMGuidance is a platform that focuses only on South Africa currently, but plans to spread further throughout the continent of Africa and releasing further to 11 extra countries. The platform – which is accessible via Android and iOS apps – has seen over 5,000 medical professionals register and use the platform since its launch, with at least 80 per cent of this user-base growth via word of mouth. More than 20 medical institutions, as well as the South African Department of Health, publish their clinical guidelines through EMGuidance.

Initially launched in July of last year, and last week named the winner of the South African leg of the Seedstars World competition, EMGuidance provides a centralised, digital access point for locally relevant clinical guidelines on behalf of a wide range of medical institutions, and detailed medicines information, equipping doctors with up to date information that can help to reduce inaccurate decisions at the point-of-care.

EMGuidance is South Africa’s first free, interactive, and continuously updated mobile medicines resource available. The platform has over 800 ingredients listed and boasts that it will have around 1,200 ingredients by the end of this August.

Howard Moodycliffe, chief marketing officer, explained while in an interview with Disrupt Africa that the platform allows for the “geo-location function to be enabled.”  What does this mean exactly?  EMG Technologies will be able to spread their platform to territories outsides of Africa.

Over 5,000 medical professionals have already registered and used this platform since its launch a year ago. Over 20 separate medical institutions in South Africa publish their clinical guidelines through the platform EMGuidance.

The countries that this platform will be spread to will include Egypt, Botswana, Ghana, Kenya, Namibia, Cameroon, Uganda, Tanzania, Rwanda, Sudan, and Zambia.

Moodycliffe also states that until the release of EMGuidance, medical professionals have had no means of mobile access to clinical or medicinal information. Of course, there have been websites that contain related medical information, but nothing has gone so in-depth and fully detailed as this new platform.